Meeting
2015 Gastrointestinal Cancers Symposium
Analysis of recurrence pattern and survival in locally advanced rectal cancer treated with neoadjuvant chemoradiation and surgery: 25 years of experience.
Authors
Javier A. Cienfuegos
Department of General Surgery, Clinica Universidad de Navarra, Pamplona, Spain
Javier A. Cienfuegos , Jorge Baixauli , Fernando Rotellar , Iosu Sola , Jorge Arredondo , Patricia Martfnez-Ortega , Carmen Beorlegui , Jose Luis Hernandez-Lizoain
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 744)
DOI
10.1200/jco.2015.33.3_suppl.744
Abstract #
744
Poster Bd #
E34
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.
First Author: Meng Wang
Poster
2022 ASCO Annual Meeting
A phase II trial of TGFβ type I receptor inhibitor, galunisertib, plus neoadjuvant chemoradiation in patients with locally advanced rectal cancer.
First Author: Kristina Hoot Young
Poster
2022 ASCO Annual Meeting
Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results.
First Author: Darren Cowzer
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Survival outcome and treatment response of patients with young-onset locally advanced rectal cancer (YO-LARC) receiving total neoadjuvant therapy (TNT).
First Author: Edward McKenna